These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 21273682

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions.
    Commins DL, Shaughnessy RA, Axt KJ, Vosmer G, Seiden LS.
    J Neural Transm; 1989; 77(2-3):197-210. PubMed ID: 2503586
    [Abstract] [Full Text] [Related]

  • 3. Anxiety-like behavior induced by 6-OHDA animal model of Parkinson's disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety.
    Vieira JCF, Bassani TB, Santiago RM, de O Guaita G, Zanoveli JM, da Cunha C, Vital MABF.
    Behav Brain Res; 2019 Oct 03; 371():111981. PubMed ID: 31141725
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neonatal 6-hydroxydopamine and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats.
    Gong L, Kostrzewa RM, Li C.
    J Neurochem; 1994 Oct 03; 63(4):1282-90. PubMed ID: 7931280
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dose-related effects of cysteamine treatment on hypothalamic and striatal dopamine, noradrenaline and serotonin neurotransmission.
    Vécsei L, Kovács GL, Faludi M, Bollók I, Telegdy G.
    Acta Physiol Hung; 1985 Oct 03; 66(2):213-7. PubMed ID: 2864776
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effects of serotonergic and dopaminergic lesions on sodium-sensitive [3H]mazindol binding in rat hypothalamus and corpus striatum.
    Angel I, Janowsky A, Paul SM.
    Brain Res; 1989 Dec 04; 503(2):339-41. PubMed ID: 2514010
    [Abstract] [Full Text] [Related]

  • 10. Intraventricular injection of neostigmine increases dopaminergic and noradrenergic nerve activities: hyperglycemic effects and neurotransmitters in the hypothalamus.
    Takahashi A, Ishimaru H, Ikarashi Y, Maruyama Y.
    Neurosci Lett; 1993 Jun 25; 156(1-2):54-6. PubMed ID: 7692365
    [Abstract] [Full Text] [Related]

  • 11. Effects of the ergot alkaloid elymoclavine on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VD, Konstantinova E.
    Arch Int Pharmacodyn Ther; 1986 May 25; 281(1):22-34. PubMed ID: 2428322
    [Abstract] [Full Text] [Related]

  • 12. Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: I. Effects on spontaneous and drug-induced rotational behaviour and on postmortem monoamine levels.
    Luthman J, Herrera-Marschitz M, Lindqvist E.
    Psychopharmacology (Berl); 1994 Dec 25; 116(4):443-50. PubMed ID: 7701047
    [Abstract] [Full Text] [Related]

  • 13. [Effects of schizandrol A on monoamine neurotransmitters in the central nervous system].
    Zhang L, Niu X.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Feb 25; 13(1):13-6. PubMed ID: 1678991
    [Abstract] [Full Text] [Related]

  • 14. Determination of monoamines in rat brain regions after chronic administration of lithium.
    Casado M, Aragón MC, Giménez C.
    Neurochem Res; 1989 Sep 25; 14(9):905-8. PubMed ID: 2480535
    [Abstract] [Full Text] [Related]

  • 15. Changes in brain monoaminergic neurotransmitter concentrations in rat after intracerebroventricular injection of streptozotocin.
    Ding A, Nitsch R, Hoyer S.
    J Cereb Blood Flow Metab; 1992 Jan 25; 12(1):103-9. PubMed ID: 1370067
    [Abstract] [Full Text] [Related]

  • 16. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system.
    Joyce JN.
    Exp Neurol; 1991 Sep 25; 113(3):261-76. PubMed ID: 1833219
    [Abstract] [Full Text] [Related]

  • 17. Neurochemical profile of EMD 45609 (carmoxirole), a dopamine DA2-receptor agonist.
    Haase AF, Greiner HE, Seyfried CA.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun 25; 343(6):588-94. PubMed ID: 1682817
    [Abstract] [Full Text] [Related]

  • 18. Sodium valproate induced alterations in monoamine levels in different regions of the rat brain.
    Baf MH, Subhash MN, Lakshmana KM, Rao BS.
    Neurochem Int; 1994 Jan 25; 24(1):67-72. PubMed ID: 8130737
    [Abstract] [Full Text] [Related]

  • 19. Effects of central and systemic administration of leptin on neurotransmitter concentrations in specific areas of the hypothalamus.
    Clark KA, MohanKumar SM, Kasturi BS, MohanKumar PS.
    Am J Physiol Regul Integr Comp Physiol; 2006 Feb 25; 290(2):R306-12. PubMed ID: 16210420
    [Abstract] [Full Text] [Related]

  • 20. GBR12909 stimulates hypothalamo-pituitary-adrenal activity by inhibition of uptake at hypothalamic dopamine neurons.
    Borowsky B, Kuhn CM.
    Brain Res; 1993 Jun 11; 613(2):251-8. PubMed ID: 8186972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.